MGTX
Closed
Meiragtx Holdings Plc
6.48
-0.04 (-0.61%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 6.52
Day's Range: 6.305 - 6.635
Send
sign up or login to leave a comment!
When Written:
5.35
MeiraGTx Holdings PLC is a clinical-stage gene therapy company that focuses on developing transformative gene therapies for patients suffering from serious diseases. The company's pipeline includes potential treatments for inherited retinal diseases, neurodegenerative diseases, and rare diseases.
MeiraGTx's lead product candidate, AAV-RPE65, is a gene therapy for the treatment of inherited retinal diseases caused by mutations in the RPE65 gene. The company has also developed gene therapies for the treatment of Parkinson's disease and amyotrophic lateral sclerosis (ALS).
In addition to its gene therapy pipeline, MeiraGTx has a proprietary technology platform called Salvec, which enables the company to develop and manufacture gene therapies at scale. The platform includes a suite of tools for vector design, manufacturing, and quality control.
MeiraGTx was founded in 2015 and is headquartered in New York City, with additional offices in London and Israel. The company went public in 2018 and is traded on the NASDAQ under the ticker symbol MGTX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
MeiraGTx's lead product candidate, AAV-RPE65, is a gene therapy for the treatment of inherited retinal diseases caused by mutations in the RPE65 gene. The company has also developed gene therapies for the treatment of Parkinson's disease and amyotrophic lateral sclerosis (ALS).
In addition to its gene therapy pipeline, MeiraGTx has a proprietary technology platform called Salvec, which enables the company to develop and manufacture gene therapies at scale. The platform includes a suite of tools for vector design, manufacturing, and quality control.
MeiraGTx was founded in 2015 and is headquartered in New York City, with additional offices in London and Israel. The company went public in 2018 and is traded on the NASDAQ under the ticker symbol MGTX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!